BiotechTV

•

Kanal • 5 Sendungen

Biowissenschaften

Biowissenschaften

vor 5 Tagen
Biowissenschaften

Biowissenschaften

5. März
Biowissenschaften

Biowissenschaften

Zweiwöchentlich
Biowissenschaften

Biowissenschaften

31. Mai
Biowissenschaften

Biowissenschaften

2. Feb.

vor 5 Tagen

Episode 7: Perceptive Advisors' Joe Edelman discusses how biotech investing has changed over his extensive career, and his thoughts on running an investment firm

He describes to Matt how the market has become more efficient since he started in the 1990's. He shares his perspective on single-asset vs pipeline companies, and today's M&A dynamic. Plus, his goal of being unbiased as an investor and how he tries to create an environment at Perceptive where that style is instilled in his analysts.

vor 5 Tagen

•

47 Min.
15. Juni

Episode 42: Nextech's Thilo Schroeder

Having been an early investor in many recent successes such as Revolution Medicines, Peloton, and Parabilis Medicines, he describes his investment philosophy and focus on precision oncology companies. Plus, his early life, getting hands on experience in biotech at Micromet, and learning from some of the top investors and scientific advisors in the industry.

15. Juni

•

1 Std. 5 Min.
22.09.2025

Episode 25: Atlas Venture's Bruce Booth

Bruce Booth discusses his education and early career, the structure of Atlas and the types of investments it makes, investing in assets vs platforms, and more.

22.09.2025

•

1 Std. 18 Min.
01.12.2025

Episode 29: Averin Managing Partner David Berry

He describes his early life and education, 18 years of company building at Flagship Pioneering, founding Averin (previously called Bedford Bridge) with his brother, and investing at the intersection of healthcare and technology.

01.12.2025

•

1 Std. 19 Min.
11. Jan.

Episode 32: ARCH Venture Partners' Bob Nelsen

While describing his early life in Washington and formative years at the University of Chicago that led to the founding of ARCH, he shares his thoughts on leadership, risk taking, changes he thinks are need to keep the United States competitive in life sciences, and his belief in AI's promise to transform our industry.

11. Jan.

•

1 Std. 15 Min.
10.03.2025

Episode 14: Aditum Bio's Joe Jimenez

Joe Jimenez describes the career path in consumer products that led him to pharma, his time running Novartis, and the idea to co-found Aditum Bio with his partner Mark Fishman. He explains Aditum's investment philosophy, and why they like focusing on translational medicine opportunities that are just heading into the clinic. Plus, his thoughts on making R&D more efficient.

10.03.2025

•

1 Std. 13 Min.
07.04.2025

Episode 16: RA Capital's Josh Resnick

Josh Resnick describes his career path, which includes working on the venture side of both private funds and pharma (Merck). He explains the different investment strategies of RA Capital, and talks about how the firm's Raven company building incubator fits in. Plus, his thoughts on venture investing in the current environment.

07.04.2025

•

1 Std. 12 Min.
26. Jan.

Episode 33: Pappas Capital's Art Pappas

Art Pappas describes his early career, which involved numerous overseas posts for large companies, and how it let him to eventually found Pappas Capital. He discusses the various ways the firm invests, and how having corporates partners as LPs and co-investors has been a recipe for success.

26. Jan.

•

58 Min.
22.07.2025

Metsera CEO Whit Bernard shares an update on the company's obesity programs, and comments on the state of the field post ADA

He describes data that Mestera presented at ADA for its monthly-dosed GLP1 and also its amylin analog. Plus, recent learnings about the field in general, including what orforglipron might mean for the oral therapy space and why Metsera believes in an oral peptide.

22.07.2025

•

18 Min.
9. März

Episode 36: Sofinnova Invetments' Jim Healy

He discusses learnings from his decades in venture at Sofinnova Investments including 'products vs platform', therapeutics areas of interest, modalities, and how he utilizes board seats and thinks about management teams.

9. März

•

1 Std. 2 Min.

BiotechTV covers the biotechnology sector through news, stories, podcasts, and educational videos.

Channel Website

BiotechTV

Top-Sendungen

Episode 7: Perceptive Advisors' Joe Edelman discusses how biotech investing has changed over his extensive career, and his thoughts on running an investment firm

Episode 42: Nextech's Thilo Schroeder

Episode 25: Atlas Venture's Bruce Booth

Episode 29: Averin Managing Partner David Berry

Episode 32: ARCH Venture Partners' Bob Nelsen

Episode 14: Aditum Bio's Joe Jimenez

Episode 16: RA Capital's Josh Resnick

Episode 33: Pappas Capital's Art Pappas

Metsera CEO Whit Bernard shares an update on the company's obesity programs, and comments on the state of the field post ADA

Episode 36: Sofinnova Invetments' Jim Healy

Info

BiotechTV

Top-Sendungen

Top-Folgen

Info